Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 10th May 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0701 $0.104
52 weeks $0.0600 $0.85

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Jul 07, 2016 $14.19 $14.80 $14.16 $14.71 279 000
Jul 06, 2016 $13.60 $14.43 $13.40 $14.07 269 500
Jul 05, 2016 $13.47 $14.03 $13.10 $13.67 348 900
Jul 01, 2016 $13.05 $13.66 $12.71 $13.58 321 500
Jun 30, 2016 $12.65 $13.13 $12.45 $12.96 314 100
Jun 29, 2016 $12.75 $13.19 $12.36 $12.64 379 800
Jun 28, 2016 $11.87 $12.58 $11.81 $12.40 294 900
Jun 27, 2016 $12.30 $12.35 $11.32 $11.54 538 500
Jun 24, 2016 $12.23 $12.85 $11.61 $12.42 1 659 600
Jun 23, 2016 $12.39 $13.00 $12.36 $12.99 376 200
Jun 22, 2016 $12.48 $12.88 $12.02 $12.23 282 400
Jun 21, 2016 $12.85 $12.99 $12.05 $12.49 356 400
Jun 20, 2016 $12.44 $13.09 $12.33 $12.82 320 800
Jun 17, 2016 $12.86 $12.92 $12.17 $12.18 281 900
Jun 16, 2016 $12.36 $12.76 $11.90 $12.74 208 184
Jun 15, 2016 $12.29 $12.82 $12.20 $12.44 258 330
Jun 14, 2016 $12.48 $12.70 $11.80 $12.17 256 230
Jun 13, 2016 $12.50 $13.09 $12.40 $12.43 346 331
Jun 10, 2016 $12.60 $13.20 $12.50 $12.91 411 415
Jun 09, 2016 $12.85 $13.12 $12.50 $12.95 312 501
Jun 08, 2016 $13.18 $13.39 $12.76 $13.01 233 952
Jun 07, 2016 $13.48 $13.48 $12.70 $13.01 182 729
Jun 06, 2016 $13.09 $13.75 $12.63 $13.58 270 968
Jun 03, 2016 $13.47 $13.47 $12.40 $13.02 376 906
Jun 02, 2016 $12.31 $13.54 $12.21 $13.35 434 230
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT